Click for best price
Hepatitis B Vaccines Market Size, Share 2023
| Market size in 2022 |
US$ 1051.4 million
|
Forecast Market size by 2029 |
US$ 1184.9 million
|
| Growth Rate |
CAGR of 1.7% |
Number of Pages |
72 Pages |
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines. This report contains market size and forecasts of Hepatitis B Vaccines in global, including the following market information:
Global Hepatitis B Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hepatitis B Vaccines Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Hepatitis B Vaccines companies in 2022 (%)
The global Hepatitis B Vaccines market was valued at US$ 1051.4 million in 2022 and is projected to reach US$ 1184.9 million by 2029, at a CAGR of 1.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.
The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.
Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
We surveyed the Hepatitis B Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, by Type, 2022 (%)
Yeast Derived
CHO Derived
Global Hepatitis B Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, by Application, 2022 (%)
Children
Adult
Global Hepatitis B Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Hepatitis B Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis B Vaccines revenues share in global market, 2022 (%)
Key companies Hepatitis B Vaccines sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Hepatitis B Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis B Vaccines, market overview.
Chapter 2: Global Hepatitis B Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis B Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hepatitis B Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 1051.4 million
|
| Forecast Market size by 2029 |
US$ 1184.9 million
|
| Growth Rate |
CAGR of 1.7% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B Vaccines Overall Market Size
2.1 Global Hepatitis B Vaccines Market Size: 2022 VS 2029
2.2 Global Hepatitis B Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hepatitis B Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Hepatitis B Vaccines Players in Global Market
3.2 Top Global Hepatitis B Vaccines Companies Ranked by Revenue
3.3 Global Hepatitis B Vaccines Revenue by Companies
3.4 Global Hepatitis B Vaccines Sales by Companies
3.5 Global Hepatitis B Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis B Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis B Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis B Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis B Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B Vaccines Market Size Markets, 2022 & 2029
4.1.2 Yeast Derived
4.1.3 CHO Derived
4.2 By Type - Global Hepatitis B Vaccines Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis B Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Hepatitis B Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Hepatitis B Vaccines Sales & Forecasts
4.3.1 By Type - Global Hepatitis B Vaccines Sales, 2018-2023
4.3.2 By Type - Global Hepatitis B Vaccines Sales, 2024-2029
4.3.3 By Type - Global Hepatitis B Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B Vaccines Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Hepatitis B Vaccines Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis B Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Hepatitis B Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Hepatitis B Vaccines Sales & Forecasts
5.3.1 By Application - Global Hepatitis B Vaccines Sales, 2018-2023
5.3.2 By Application - Global Hepatitis B Vaccines Sales, 2024-2029
5.3.3 By Application - Global Hepatitis B Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Hepatitis B Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Hepatitis B Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Hepatitis B Vaccines Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis B Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Hepatitis B Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Hepatitis B Vaccines Sales & Forecasts
6.3.1 By Region - Global Hepatitis B Vaccines Sales, 2018-2023
6.3.2 By Region - Global Hepatitis B Vaccines Sales, 2024-2029
6.3.3 By Region - Global Hepatitis B Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Hepatitis B Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Hepatitis B Vaccines Sales, 2018-2029
6.4.3 US Hepatitis B Vaccines Market Size, 2018-2029
6.4.4 Canada Hepatitis B Vaccines Market Size, 2018-2029
6.4.5 Mexico Hepatitis B Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Hepatitis B Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Hepatitis B Vaccines Sales, 2018-2029
6.5.3 Germany Hepatitis B Vaccines Market Size, 2018-2029
6.5.4 France Hepatitis B Vaccines Market Size, 2018-2029
6.5.5 U.K. Hepatitis B Vaccines Market Size, 2018-2029
6.5.6 Italy Hepatitis B Vaccines Market Size, 2018-2029
6.5.7 Russia Hepatitis B Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Hepatitis B Vaccines Market Size, 2018-2029
6.5.9 Benelux Hepatitis B Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Hepatitis B Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Hepatitis B Vaccines Sales, 2018-2029
6.6.3 China Hepatitis B Vaccines Market Size, 2018-2029
6.6.4 Japan Hepatitis B Vaccines Market Size, 2018-2029
6.6.5 South Korea Hepatitis B Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Hepatitis B Vaccines Market Size, 2018-2029
6.6.7 India Hepatitis B Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Hepatitis B Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Hepatitis B Vaccines Sales, 2018-2029
6.7.3 Brazil Hepatitis B Vaccines Market Size, 2018-2029
6.7.4 Argentina Hepatitis B Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis B Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Hepatitis B Vaccines Sales, 2018-2029
6.8.3 Turkey Hepatitis B Vaccines Market Size, 2018-2029
6.8.4 Israel Hepatitis B Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Hepatitis B Vaccines Market Size, 2018-2029
6.8.6 UAE Hepatitis B Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis B Vaccines Major Product Offerings
7.1.4 GSK Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 NCPC
7.2.1 NCPC Company Summary
7.2.2 NCPC Business Overview
7.2.3 NCPC Hepatitis B Vaccines Major Product Offerings
7.2.4 NCPC Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 NCPC Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Hepatitis B Vaccines Major Product Offerings
7.3.4 Merck Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Bio Kangtai
7.4.1 Bio Kangtai Company Summary
7.4.2 Bio Kangtai Business Overview
7.4.3 Bio Kangtai Hepatitis B Vaccines Major Product Offerings
7.4.4 Bio Kangtai Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Bio Kangtai Key News & Latest Developments
7.5 Dynavax
7.5.1 Dynavax Company Summary
7.5.2 Dynavax Business Overview
7.5.3 Dynavax Hepatitis B Vaccines Major Product Offerings
7.5.4 Dynavax Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Dynavax Key News & Latest Developments
7.6 Hissen
7.6.1 Hissen Company Summary
7.6.2 Hissen Business Overview
7.6.3 Hissen Hepatitis B Vaccines Major Product Offerings
7.6.4 Hissen Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Hissen Key News & Latest Developments
7.7 KM Biologics
7.7.1 KM Biologics Company Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis B Vaccines Major Product Offerings
7.7.4 KM Biologics Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 KM Biologics Key News & Latest Developments
7.8 LG Life Sciences
7.8.1 LG Life Sciences Company Summary
7.8.2 LG Life Sciences Business Overview
7.8.3 LG Life Sciences Hepatitis B Vaccines Major Product Offerings
7.8.4 LG Life Sciences Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 LG Life Sciences Key News & Latest Developments
7.9 Serum Institute
7.9.1 Serum Institute Company Summary
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Hepatitis B Vaccines Major Product Offerings
7.9.4 Serum Institute Hepatitis B Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Serum Institute Key News & Latest Developments
8 Global Hepatitis B Vaccines Production Capacity, Analysis
8.1 Global Hepatitis B Vaccines Production Capacity, 2018-2029
8.2 Hepatitis B Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis B Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis B Vaccines Supply Chain Analysis
10.1 Hepatitis B Vaccines Industry Value Chain
10.2 Hepatitis B Vaccines Upstream Market
10.3 Hepatitis B Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis B Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hepatitis B Vaccines in Global Market
Table 2. Top Hepatitis B Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatitis B Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatitis B Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Hepatitis B Vaccines Sales by Companies, (M Doses), 2018-2023
Table 6. Global Hepatitis B Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatitis B Vaccines Price (2018-2023) & (USD/Doses)
Table 8. Global Manufacturers Hepatitis B Vaccines Product Type
Table 9. List of Global Tier 1 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis B Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hepatitis B Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatitis B Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hepatitis B Vaccines Sales (M Doses), 2018-2023
Table 15. By Type - Global Hepatitis B Vaccines Sales (M Doses), 2024-2029
Table 16. By Application ? Global Hepatitis B Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hepatitis B Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatitis B Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hepatitis B Vaccines Sales (M Doses), 2018-2023
Table 20. By Application - Global Hepatitis B Vaccines Sales (M Doses), 2024-2029
Table 21. By Region ? Global Hepatitis B Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hepatitis B Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatitis B Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hepatitis B Vaccines Sales (M Doses), 2018-2023
Table 25. By Region - Global Hepatitis B Vaccines Sales (M Doses), 2024-2029
Table 26. By Country - North America Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatitis B Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hepatitis B Vaccines Sales, (M Doses), 2018-2023
Table 29. By Country - North America Hepatitis B Vaccines Sales, (M Doses), 2024-2029
Table 30. By Country - Europe Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatitis B Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hepatitis B Vaccines Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Hepatitis B Vaccines Sales, (M Doses), 2024-2029
Table 34. By Region - Asia Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatitis B Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hepatitis B Vaccines Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Hepatitis B Vaccines Sales, (M Doses), 2024-2029
Table 38. By Country - South America Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatitis B Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hepatitis B Vaccines Sales, (M Doses), 2018-2023
Table 41. By Country - South America Hepatitis B Vaccines Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatitis B Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hepatitis B Vaccines Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Hepatitis B Vaccines Sales, (M Doses), 2024-2029
Table 46. GSK Company Summary
Table 47. GSK Hepatitis B Vaccines Product Offerings
Table 48. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. NCPC Company Summary
Table 51. NCPC Hepatitis B Vaccines Product Offerings
Table 52. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 53. NCPC Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Hepatitis B Vaccines Product Offerings
Table 56. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Bio Kangtai Company Summary
Table 59. Bio Kangtai Hepatitis B Vaccines Product Offerings
Table 60. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 61. Bio Kangtai Key News & Latest Developments
Table 62. Dynavax Company Summary
Table 63. Dynavax Hepatitis B Vaccines Product Offerings
Table 64. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 65. Dynavax Key News & Latest Developments
Table 66. Hissen Company Summary
Table 67. Hissen Hepatitis B Vaccines Product Offerings
Table 68. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 69. Hissen Key News & Latest Developments
Table 70. KM Biologics Company Summary
Table 71. KM Biologics Hepatitis B Vaccines Product Offerings
Table 72. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 73. KM Biologics Key News & Latest Developments
Table 74. LG Life Sciences Company Summary
Table 75. LG Life Sciences Hepatitis B Vaccines Product Offerings
Table 76. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 77. LG Life Sciences Key News & Latest Developments
Table 78. Serum Institute Company Summary
Table 79. Serum Institute Hepatitis B Vaccines Product Offerings
Table 80. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2018-2023)
Table 81. Serum Institute Key News & Latest Developments
Table 82. Hepatitis B Vaccines Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 83. Global Hepatitis B Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Hepatitis B Vaccines Production by Region, 2018-2023 (M Doses)
Table 85. Global Hepatitis B Vaccines Production by Region, 2024-2029 (M Doses)
Table 86. Hepatitis B Vaccines Market Opportunities & Trends in Global Market
Table 87. Hepatitis B Vaccines Market Drivers in Global Market
Table 88. Hepatitis B Vaccines Market Restraints in Global Market
Table 89. Hepatitis B Vaccines Raw Materials
Table 90. Hepatitis B Vaccines Raw Materials Suppliers in Global Market
Table 91. Typical Hepatitis B Vaccines Downstream
Table 92. Hepatitis B Vaccines Downstream Clients in Global Market
Table 93. Hepatitis B Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis B Vaccines Segment by Type in 2022
Figure 2. Hepatitis B Vaccines Segment by Application in 2022
Figure 3. Global Hepatitis B Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hepatitis B Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Hepatitis B Vaccines Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Vaccines Revenue in 2022
Figure 9. By Type - Global Hepatitis B Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Hepatitis B Vaccines Price (USD/Doses), 2018-2029
Figure 13. By Application - Global Hepatitis B Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Hepatitis B Vaccines Price (USD/Doses), 2018-2029
Figure 17. By Region - Global Hepatitis B Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hepatitis B Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 23. US Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 37. China Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hepatitis B Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hepatitis B Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hepatitis B Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hepatitis B Vaccines Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production Hepatitis B Vaccines by Region, 2022 VS 2029
Figure 54. Hepatitis B Vaccines Industry Value Chain
Figure 55. Marketing Channels
